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Recent Advances using [Cp*Co(CO)I2] Catalysts as a Powerful Tool 
for C-H Functionalisation 
 
Paula G. Chirila and Christopher J. Whiteoak* 
 
Expansion of the synthetic chemists’ toolbox is currently a topic of great interest, with successes providing access to novel 
compounds and more efficient routes towards new and known pharmaceuticals and agrochemicals. In this context, the 
development and application of first-row transition metal-catalysed C-H functionalisation protocols is seen as a key 
opportunity. This perspective provides a brief background of the discovery and application of high-valent cobalt-catalysis 
in C-H functionalisation, before detailing examples of recent advances in this field using the powerful [Cp*Co(CO)I2] 
catalysts for both terminal couplings and heterocycle formation. Finally, a discussion on the detection and isolation of 
elusive reactive intermediates in high-valent cobalt-catalysed C-H functionalisation, shedding light on how these catalyst 
systems operate, will be provided. 
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1. Introduction 
Development of new methodologies for selective formation of 
bonds provides one of the key challenges/opportunities in 
modern day synthetic chemistry. Once developed, these 
technologies can enable controlled access to a range of  
 
 
 
 
 
important molecules from chemical intermediates and 
pharmaceuticals, to agrochemicals, amongst many others. 
  
 In this context, the development of transition metal 
catalysed methodologies has attracted significant attention, 
resulting from the often improved selectivities observed when 
compared with traditional organic synthetic routes. One of the 
most important contributions to the field of bond formation 
over recent decades, was the development of palladium cross-
coupling, a field which continues to receive significant 
interest.1 Since its conception, palladium cross-coupling has 
become a key tool in the synthetic chemists’ toolbox. Indeed, 
the importance of these contributions to the field of bond 
formation was highlighted by the awarding of the 2010 Nobel 
prize to Heck, Negishi and Suzuki.2 The major drawbacks of 
these palladium-catalysed bond forming reactions is the 
requirement for pre-functionalised substrates (eg. halides or 
triflates) and the production of halogenated wastes. One way 
of directly addressing these problems is to develop 
methodologies which employ a direct C-H activation step. In 
the case of palladium, significant advancements have been 
made in this field, providing protocols which no longer require 
pre-functionalised substrates and that produce less halogen-
containing wastes.3,4 
 Whilst success in direct C-H functionalisation using 
palladium has been achieved, palladium itself is relatively 
expensive. As a result, a lot of attention has recently been 
directed towards the use of cheaper first-row transition 
metals, such as nickel and copper, and of particular interest to 
this perspective, cobalt.5-8 
The identification of cobalt as a suitable metal for 
catalysing C-H functionalisation protocols is not entirely 
surprising given the relatively well developed field of rhodium-
catalysed C-H functionalisation.9,10 Researchers have in many 
cases taken the opportunity to reproduce some of these 
reactivities with significantly cheaper cobalt, which often, as 
will be discussed within this perspective, has led to unexpected 
and contrasting reaction outcomes. Cobalt-catalysed C-H 
functionalisation can be divided into two distinct categories; a 
low-valent approach (where the active cobalt catalyst is 
typically in the cobalt(0) or cobalt(I) oxidation state) and the 
high-valent approach (where the active cobalt catalyst is 
typically in the cobalt(III) oxidation state). From herein, we will 
use these definitions when discussing the different approaches 
to the use of cobalt in C-H functionalisation. 
 
Scheme 1. Cobalt(0)-catalysed carbonylation of Schiff-bases for the formation of 
phthalimidines, via a C-H activation step, reported by Murahashi. 
 
Scheme 2. Cobalt(III)-mediated trifluoroacetylation of aromatic compounds 
operating via a proposed SET mechanism, reported by Kochi and co-workers. 
Cobalt-catalysed bond formation has been long known, 
with its origins being provided as far back as 1941 by Kharasch 
and Fields.11 This early work reported the cobalt(II)-catalysed 
coupling of organic halides with Grignard reagents. Although 
not a C-H functionalisation protocol, it provided the first 
example of C-C coupling using cobalt catalysis. The first 
example of cobalt-catalysed C-H functionalisation came a few 
years later, in 1955, when Murahashi provided a low-valent 
cobalt-catalysed carbonylation protocol (Scheme 1).12 This 
protocol provided access to phthalimidines through an 
annulation reaction of Schiff-bases and carbon monoxide, 
using Co2(CO)8 as catalyst. 
Since the first discovery of cobalt(0)-catalysed C-H 
functionalisation, the most significant applications of cobalt in 
catalysis have come in the fields of hydroformylation13 and the 
development of the Pauson-Khand reaction.14,15 It was not 
until 1973 that further advances in cobalt-catalysed C-H 
functionalisation were made. In this pioneering work, Kochi 
and co-workers presented the first example of a high-valent 
approach towards the preparation of aromatic 
trifluoroacetates through the functionalisation of aromatic 
substrates (Scheme 2).16 Although a stoichiometric process 
requiring 2.0 equivalents of Co(OTf)3 for each molecule of 
substrate and using trifluoroacetic acid (TFA) as solvent, the 
authors were able to study and elucidate a novel Single 
Electron Transfer (SET) mechanism for direct cobalt-catalysed 
C-H functionalisation. 
Thereafter, the low-valent catalytic approach was further 
advanced by Kisch and co-workers in 1994,17 reporting the 
ortho-alkenylation of aromatic azo compounds. This low-valent 
approach has since provided a significant number of 
potentially useful bond forming protocols, but is outside the 
scope of this perspective.18,19 Meanwhile, development of 
catalytic protocols using high-valent approaches remained a 
significant hurdle to overcome, with only further proof-of-
concept stoichiometric examples reported by Broderick/Legg 
and co-workers20,21 and Avilés and co-workers.22 
A significant catalytic breakthrough was made in the field 
by Matsunaga/Kanai and co-workers in 2013.23 This work 
introduced the first Cp*CoIII-type catalyst, whereby a 
[Cp*Co(benzene)](PF6)2 complex was shown to catalyse the 
coupling of 2-arylpyridine substrates with sulfonyl imines and α,β-unsaturated ketones (Scheme 3a for sulfonyl imine 
example), the same group also extended this protocol to 
indole-based substrates soon afterwards.24 More recently, in 
2014, Matsunaga/Kanai and co-workers further disclosed that 
a [Cp*Co(CO)I2] complex, in combination with a silver salt 
(AgSbF6), displayed superior activity for a C-N bond forming 
protocol when compared to the [Cp*Co(benzene)](PF6)2 
catalyst (Scheme 3b).25 This finding has since led to an 
explosion of interest in developing catalytic protocols based on 
the readily synthesisable [Cp*Co(CO)I2] and related complexes 
(Scheme 4). This complex is analogous to the previously 
established and successful Cp*RhIII-type catalysts.9 It should 
however be noted that successful coupling protocols have 
since been achieved using the [Cp*Co(benzene)](PF6)2 catalyst, 
 
 
  
 
 
Scheme 3. Examples of two distinct types of high-valent catalytic C-H 
functionalisation protocols using cobalt as catalyst. (a) First example of Cp*CoIII-
type catalytic protocol. (b) First example of the use of [Cp*Co(CO)I2] as catalyst. 
(c) First example of an 8-aminoquinoline assisted cobalt-catalysed protocol. (d) 
First example of a cobalt-catalysed SET approach. (e) First example of a remote 
C-H functionalisation utilising a cobalt-catalysed SET approach.  
 
Scheme 4. (a) Preparation of [Cp*Co(CO)I2] from Co2(CO)8.
25 (b) Preparation of 
[Cp*Co(MeCN)3](SbF6)2 from [Cp*Co(CO)I2].
27 (d) Preparation of [Cp*CoI2]2 from 
[Cp*Co(CO)I2].
28 
 particularly from the research groups of 
Kanai/Matsunaga and Ellman.23,24,26 
Further development of the Cp*CoIII-type catalyst system 
has also led to the use of a single component catalyst, 
[Cp*Co(MeCN)3](SbF6)2, precluding the use of silver salts in the 
reaction.27 Interestingly, the corresponding dimeric complex, 
[Cp*CoI2]2, which can be easily prepared from [Cp*Co(CO)I2] 
by refluxing in octane (Scheme 4c), has also been found to be 
active and in some cases, is found to be more active than the 
[Cp*Co(CO)I2] catalyst.
28 
Around the same time as the development of the 
[Cp*Co(CO)I2] catalyst, Daugulis and co-worker identified 
another route towards high-valent cobalt-catalysed C-H 
functionalisation with the aid of an 8-aminoquinoline directing 
group (Scheme 3c).29 Whilst both of these approaches are 
proposed to proceed by a Concerted Metalation 
Deprotonation (CMD) process during the C-H activation step, 
examples of SET-based cobalt-catalysed C-H functionalisation 
protocols have also been reported. In 2015 Niu/Song and co-
workers provided an example of the coupling of alcohols to 
aromatic and olefinic carboxamides, with the alcohol acting as 
both solvent and coupling partner (Scheme 3d).30 During this 
work the authors made the unexpected discovery that the 
kH/kD value was approximately 1. This was an unusual result as 
in most other high-valent C-H functionalisation protocols, the 
C-H activation step is usually determined as the rate-limiting 
step, resulting in kH/kD values significantly higher than 1. Later, 
Niu/Wei and co-workers studied the mechanistic pathway of 
this conversion in further detail (DFT study) and confirmed 
that it most likely proceeds through the initially proposed SET 
mechanism.31 
More recently, in 2016, Ribas/Whiteoak and co-workers 
provided the first example of a remote C-H functionalisation 
(nitration) of 8-aminoquinolines using a SET approach (Scheme 
3e).32 Again, in this report the C-H activation step was found 
not to be the rate limiting step, as the kH/kD value was 
approximately 1. This example is closely related to the 
mechanism proposed by Stahl and co-workers where copper is 
employed for the remote chlorination of 8-aminoquinoline 
compounds.33 This cobalt-catalysed remote C-H 
functionalisation mechanism has more recently been 
expanded to perfluoroalkylation by Niu/Song and co-
workers.34 
 Whilst recent reviews into the application of high-
valent cobalt-catalysed C-H functionalisation35 and more 
recently, specifically the Cp*CoIII catalysis have been 
published,36,37 in this perspective the intention is to highlight 
the potential application of the related complexes 
[Cp*Co(CO)I2], [Cp*CoI2]2 and [Cp*Co(MeCN)3](SbF6)2 in a 
different way. This perspective will consider and group the 
specific substrates that have been utilised (Terminal 
couplings), whilst also showing the different routes towards 
heterocyclic products (Heterocycle formation). Finally, the 
perspective will provide a short discussion of recent examples 
of the characterisation of organometallic cobalt species, 
achieved through C-H activation, which are implicated as 
reactive intermediates in high-valent cobalt-catalysed C-H 
  
functionalisation protocols. This overview is intended to be a 
thorough, but not exhaustive description of the state of 
[Cp*Co(CO)I2] catalysed C-H functionalisation up to and 
including May 2017. 
2. Terminal couplings using [Cp*Co(CO)I2] 
catalysts 
In this section, a wide range of examples of terminal 
couplings using [Cp*Co(CO)I2] catalysts will be discussed. 
These couplings have been grouped by substrate type, 
allowing for a clear overview of the current state of the art. In 
many cases, couplings have been found to be substrate-type 
specific. This specificity/limitation can be exemplified by Wang 
and co-workers; in their recent article describing the 
trifluoromethylthiolation of 2-arylpyridines, where the 
catalytic protocol was unable to convert other common 
substrates, such as benzamides and an indole derivative 
containing a pyridine directing group.38 
To date, indole derivatives with pyridine or pyrimidine 
directing groups have provided a significant number of 
examples of terminal couplings with the [Cp*Co(CO)I2] 
catalyst. Herein, we will discuss couplings with indole-based 
substrates, followed by 2-arylpyridines/related compounds, 
and finally miscellaneous examples. 
A. Examples using indole-based substrates containing pyridine and 
pyrimidine directing groups 
The [Cp*Co(CO)I2] catalyst has been demonstrated to be 
competent for a wide range of terminal couplings to indole-
based substrates containing pyridine and pyrimidine directing 
groups (Scheme 5). Indoles bearing these directing groups can 
easily be prepared in high yield, through reaction of the indole 
with either 2-bromopyridine or 2-chloropyrimidine in the 
presence of sodium hydride. Furthermore, they can also be 
easily removed by heating with sodium ethoxide in DMSO. This 
directing group approach towards couplings to indoles 
provides specificity for couplings at the 2-position,
 
Scheme 5. Examples of reported C-C Couplings using indole-based substrates containing pyridine and pyrimidine directing groups. General conditions for each example: (i) 0.1 
mmol substrate, 0.15 mmol allyl alcohol, 5.0 mol% [Cp*Co(CO)I2], 10 mol% AgOTf, 10 mol% AgOAc, 1,2-DCE, 60 
oC, 8 h. (ii) 0.40 mmol substrate, 0.80 mmol allyl carbonate, 0.5 
mol% [Cp*Co(CO)I2], 1.25 mol% AgSbF6, 5.0 mol% PivOH, 1,2-DCE, rt, 4-24 h. (iii) 0.3 mmol substrate, 0.36 mmol α-diazomalonate, 5.0 mol% [Cp*Co(CO)I2], 10 mol% AgSbF6, 1,2-
DCE, 100 oC, 20-48 h. (iv) 0.25 mmol substrate, 0.275 mmol alkyne, 2.5 mol% [Cp*CoI2]2, 10 mol% AgSbF6, 2.0 equiv. K2CO3, TFE, 25 
oC, 18 h. (v) 0.10 mmol substrate, 0.12 mmol 
hyper-valent iodine-alkyne reagent, 5.0 mol% [Cp*Co(CO)I2], 10 mol% AgF, 3.0 equiv. Mg(OCH3)2, TFE, 110 
oC, 24 h. (vi) 0.20 mmol substrate, 0.20 mmol phenylacetylene, 5.0 mol% 
[Cp*Co(CO)I2], 10 mol% AgSbF6, 1,2-DCE, rt, 10 min. (vii) 0.5 mmol substrate, 0.6 mmol vinylcyclopropane, 10 mol% [Cp*Co(CO)I2], 20 mol% AgOTf, 20 mol% NaOPiv, 1,2-DCE, 50 
oC, 20 h. (viii) 0.20 mmol substrate, 0.24 mmol gem-difluorostyrene, 5.0 mol% [Cp*Co(MeCN)3](SbF6)2, 2.0 equiv. Ca(OH)2, TFE, 45 
oC, 24 h. (ix) 0.20 mmol substrate, 0.25 mmol 
ketenimine, 2.5 mol% [Cp*Co(CO)I2], 7.5 mol% AgNTf2, 1,2-DCE, 80 
oC, 10 h. (x) 0.50 mmol substrate, 0.72 mmol allene, 5.0 mol% [Cp*Co(CO)I2], 10 mol% AgSbF6, 1,2-DCE or 1,4-
dioxane, 100-120 oC, 20 h. (xi) 0.25 mmol substrate, 0.45 mmol acrolein or α,β-unsaturated ketone, 2.5 mol% [Cp*Co(CO)I2], 5.0 mol% AgSbF6, 2.0 equiv. KOPiv, TFE, 70 oC, 16 h. 
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which is in contrast to traditional electrophilic substitution 
reactions which typically occur at the 3-position, thus 
providing new selectivity. This methodology was first 
described by Bergman and Venemalm in 1992, using carbon 
dioxide and lithium.39 Herein, a selection of both C-C and C-X 
couplings will be discussed to exemplify the potential of the 
[Cp*Co(CO)I2] catalyst for couplings at the 2-position of 
indoles. 
C-C couplings. The first C-C coupling to indoles using the 
[Cp*Co(CO)I2] catalyst was reported by Matsunaga/Kanai and 
co-workers in 2015.40 This report described the dehydrative 
allylation of indoles with allylic alcohols (Scheme 5i). This 
conversion was found to be more efficient with [Cp*Co(CO)I2] 
catalyst compared with the analogous [Cp*RhCl2]2 catalyst. 
The reason for this is likely a result of the increased 
oxophillicity of the [Cp*Co]2+ cation compared with the 
[Cp*Rh]2+ cation, facilitating the dehydrative C-H allylation 
with allyl alcohols through a β-hydroxide elimination pathway, 
rather than a typical β-hydride elimination pathway. The 
reaction proceeds smoothly with good to excellent yields with 
a range of differently substituted indole substrates and allylic 
alcohols (both terminal and internal). The report also disclosed 
that a pyrrole bearing a pyrimidine directing group could also 
be converted, although this resulted in a double 
functionalisation at the 2 and 5-positons. Furthermore, 1-
phenyl-pyrazole was also successfully converted under the 
optimised reaction conditions. 
Shortly after this initial report, Glorius and co-workers 
extended the scope of this allylation protocol to the use of allyl 
carbonates as coupling partners (Scheme 5ii).41 In this study, 
the authors noted that when the methyl carbonate was 
replaced with tert-butyl carbonate, the E/Z ratio could be 
increased, indicating that the conformation of the carbonate 
at the step of olefin insertion to the organometallic cobalt 
intermediate determines the relative configuration of cobalt 
and carbonate in the following intermediate and hence the 
geometry of the final olefin product. 
Alkylation has been achieved using α-diazomalonates as 
coupling partners, reported by Wang and co-workers around 
the same time as the previous two examples (Scheme 5iii).42 
These α-diazomalonates have previously been shown to be 
excellent carbene precursors in transition-metal-catalysed 
carbene transfer reactions, generating highly reactive metal 
carbene species with extrusion of N2.
43 The use of α-
diazomalonates in C-H functionalisation has been previously 
reported by Yu and co-workers using the [Cp*RhCl2]2 
catalyst,44 This cobalt-catalysed allylation methodology was 
found to be able to convert a wide range of substituted 
indoles, N-arylpyrazoles and even pyrrole itself, although 
another common substrate class, 2-arylpyridines, could not be 
converted. The authors also provided an intriguing example 
using β-methylindole, which provided an unexpected route 
towards the mono-ester through a proposed 
decarbalkoxylation step. 
In addition to allylations, there are also reports of 
alkynylation protocols using the [Cp*Co(CO)I2] catalysts. Both 
the groups of Ackermann and Shi have made contributions in 
this field. Alkynylations using bromoalkynes as coupling 
partners were reported by Ackermann and co-workers 
(Scheme 5iv),45 with the conversion found to operate at room 
temperature. This protocol was also able to convert pyrroles 
with similar success and upon further increasing the 
bromoalkyne from 1.1 to 2.0 equivalents, dialkynylation of 
pyrrole was also achievable. In contrast, Shi and co-workers 
employed a different approach, using hyper-valent iodine-
alkyne reagents (Scheme 5v)46 in similarity to the previous 
[Cp*RhCl2]2 catalysed example reported by Li and co-workers 
in 2014.47 This protocol exhibited tolerance to a wide range of 
functionalised indoles, including β-cyanoindole. The drawback 
to this methodology is the elevated temperature when 
compared to the protocol of Ackermann and co-workers. 
Further use of alkynes as coupling partners was reported in 
2016, whereby Chen/Yu and co-workers demonstrated that 
alkenylation could be realised when using phenylacetylene as 
the coupling partner (Scheme 5vi).48 This reaction proceeded 
extremely rapidly, with almost quantitative yield after only 10 
minutes at room temperature, although only one example is 
provided of indole substrates. 
Vinylcyclopropanes have also been used as coupling 
partners in [Cp*Co(CO)I2] catalysed C-C bond formation 
protocols. In 2016, Ackermann and co-workers presented an 
example of the coupling of vinylcyclopropanes with indole-
based substrates bearing a pyridyl directing group (Scheme 
5vii).49 This protocol is notable as it delivers the 
thermodynamically less stable Z-alkenes with excellent 
diastereoselectivity. In particular, the amount of Z-alkene 
formed is significantly higher with [Cp*Co(CO)I2] catalysis 
compared with corresponding rhodium catalysis. The authors 
also provided a mechanism which is evidenced by DFT studies, 
which indicates that the higher amount of Z-alkene with cobalt 
catalysis results from a shorter Co-C bond length in the Z-
organometallic intermediate species.  
The inclusion of fluorine atoms into organic molecules 
remains an important challenge in synthetic chemistry, 
enhancing the stability, lipophilicity and bioavailability of 
molecules. Li and co-workers have provided an intriguing 
example of an α-fluoroalkenylation using gem-
difluorostyrenes as coupling partners (Scheme 5viii).50 This 
protocol provides monofluoroalkenes with excellent Z-
selectivity and yield. In this example the 
[Cp*Co(MeCN)3](SbF6)2 catalyst is used in order to eliminate 
the need for addition of a silver salt. The mechanism is 
proposed to pass through a key β-F elimination step and is 
similar to the [Cp*Rh(MeCN)3](SbF6)2 catalysed 
fluoroalkenylation reported by Feng/Loh and co-worker.51 The 
optimised catalytic protocol is also able to convert compounds 
bearing other heterocyclic directing groups (Scheme 9xi). 
The use of ketenimines as coupling partners for 
enaminylation was reported by Lu/Wang and co-workers 
(Scheme 5ix).52 The products obtained from this protocol can 
be easily converted into 3H-pyrrolo[1,2-a]indol-3-ones, which 
are potentially important medicinal compounds, through a 
base-promoted cyclisation reaction in a second separate or 
  
one-pot step (Scheme 6). This protocol demonstrates the 
potential of one-pot reactions for construction of compounds  
 
Scheme 6. Example of a facile one-pot preparation of 3H-pyrrolo[1,2-a]indol-3-
ones using cobalt-catalysed C-H functionalisation as the key step. 
with high molecular complexity, using an initial cobalt-
catalysed C-H functionalisation as the key step. In addition, the 
protocol is also able to convert indoline, pyrrole and phenyl 
substrates bearing the pyrimidine directing group, albeit in the 
case of indoline the conversion proceeds in relatively modest 
yield. 
Recently, in 2017, the research groups of Ackermann and Li 
have reported [Cp*Co(CO)I2] catalysed hydroarylation 
protocols (Scheme 5x and xi, respectively). Allenes were 
employed as coupling partners by Ackermann and co-workers 
providing α,β-unsaturated products.53 In this report, the 
authors provide a detailed mechanistic and computational 
study, which combine to provide evidence for a mechanism 
which involves C-H cobaltation of the substrate, migratory 
insertion of the allene, intermediate isomerisation and a final 
proto-demetallation step. It was also shown to be possible to 
convert β-methylindole derivatives and also 2-phenylpyridine 
substrates (Scheme 9xiii). Meanwhile, Li and co-workers 
demonstrated that a variety of α,β-unsaturated ketones and 
glyoxylate could be used as coupling partners.54 Competition 
experiments from this work provided several important 
findings; that glyoxylate is more reactive than the α,β-
unsaturated ketones; acrolein is more reactive than α,β-
unsaturated ketones; and that aryl-α,β-unsaturated ketones 
are less reactive than aliphatic-α,β-unsaturated ketones. 
Again, it was possible to convert β-substituted indole 
derivatives and the pyrrole derivative, albeit in modest yield.
 
 
Scheme 7. Examples of reported C-X Couplings using indole-based substrates containing pyridine and pyrimidine directing groups. General conditions for each 
example: (i) 0.20 mmol substrate, 0.30 mmol sulfonyl azide, 2.5 mol% [Cp*Co(CO)I2], 5.0 mol% AgSbF6, 5.0 mol% KOAc, 1,2-DCE, 100 
oC, 12 h. (ii) 0.40 mmol substrate, 
0.48 mmol N-cyano-N-phenyl-p-toluenesulfonamide (NCTS), 0.5-5.0 mol% [Cp*Co(CO)I2], 1.0-10 mol% AgSbF6, 2.0-10 mol% NaOAc, 1,2-DCE, 110 
oC, 12-24 h. (iii) 0.50 
mmol substrate, 0.75 NCTS, 2.5 mol% [Cp*Co(CO)I2], 5.0 mol% AgSbF6, 5.0 mol% KOAc, 1,2-DCE, 120 
oC, 16 h. (iv) 0.20 mmol substrate, 0.22 mmol 1,4,2-dioxazol-5-
one, 2.5 mol% [Cp*Co(MeCN)3](SbF6)2, 1,2-DCE, 80 
oC, 12 h. (v) 0.50 mmol substrate, 0.60 mmol 1,4,2-dioxazol-5-one, 2.5-5.0 mol% [Cp*Co(CO)I2], 5.0-10 mol% 
AgSbF6, 5.0-10 mol% NaOAc, 1,2-DCE, 70-100 
oC, 16 h. (vi) 0.80 mmol substrate, 0.40 mmol phosphoryl azide (yield based on phosphoryl azide), 5.0 mol% [Cp*CoI2]2, 
20 mol% AgSbF6, 1,4-dioxane, 60 
oC, 36 h. (vii) 0.50 mmol substrate, 1.0 mmol thiol, 10 mol% [Cp*Co(CO)I2], 1.5 equiv. Cu(OAc)2, 25 mol% In(OTf)3, 1.25 equiv. 
benzoquinone, 1,4-dioxane, 60 oC, 5 h. 
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C-X couplings. In comparison to the number of C-C 
couplings which have been reported using the [Cp*Co(CO)I2] 
catalyst, there are comparatively fewer examples of C-X 
couplings. Indeed, one of the key challenges in modern-day 
cross-coupling remains the selective formation of C-X bonds. 
The first reported use of the [Cp*Co(CO)I2] complex in 
catalytic C-H functionalisation was actually a C-X bond forming 
protocol, as previously mentioned. In 2014, Matsunaga/Kanai 
and co-workers demonstrated for the first time the increased 
efficiency of the [Cp*Co(CO)I2] catalyst over the 
[Cp*Co(benzene)](PF6)2 catalyst for the amidation of indoles 
bearing a pyrimidine directing group in combination with 
aryl/alkyl sulfonyl azides as coupling partners (Scheme 7i).25 
This conversion is analogous to the [Cp*Rh(MeCN)3](SbF6)2 
catalysed protocol reported by Zhou/Li and co-workers in 
2012.55 Under the optimised conditions a wide range of 
substituted indoles and aryl/alkyl sulfonyl azides could be 
successfully coupled in excellent yields. More recently the 
same research group have extended the scope of this protocol 
towards the use of phosphoryl azides as coupling partners, 
although in this example 1,4-dioxane was found to be the 
optimal solvent in combination with the [Cp*CoI2]2 catalyst 
(Scheme 7vi).28 
In late 2014, both the groups of Glorius and Ackermann 
simultaneously reported a [Cp*Co(CO)I2] catalysed cyanation 
protocol using N-cyano-N-phenyl-p-toluenesulfonamide (NCTS) 
as cyanating agent (Scheme 7ii and iii).27,56 In both examples 
the catalyst system tolerates a wide variety of substituted 
indoles and also β-methylindole. In addition, Ackermann and 
co-worker demonstrated that pyrrole and thiophenes could 
also be cyanated using the optimised catalytic protocol in good 
to quantitative yields. 
Further examples of amidation protocols were developed 
using 1,4,2-dioxazol-5-ones as amidating agent, reported by 
Jiao and co-workers (Scheme 7iv).57 This amidation agent is 
relatively facile to prepare and during the amidation reaction 
CO2 is extruded as the only by-product. The optimised 
amidation protocol was also found to be able to convert a 
wide range of substrates (eg. 2-phenylpyridines, 6-arylpurines 
amongst others; see Scheme 9vi). This methodology was 
further exemplified by Ackermann and co-workers in 2016 
(Scheme 7v), who also demonstrated conversion of 
phenyloxazolines and phenyloxazines, along with pyrrole 
(Scheme 9vii).58 
Most recently, in 2016, Glorius and co-workers reported a 
thiolation protocol through the dehydrogenative cross-
coupling with thiols (Scheme 7vii).59 In addition to thiolation, 
this report also contains an example of selenation through use 
of diphenyl diselenide as coupling partner. Interestingly, when 
the [Cp*Co(CO)I2] catalyst was not included in the reaction 
protocol, β-thiolation products were selectively obtained 
indicating the importance of cobalt catalysis to the reaction. In 
addition, the authors also attempted to provide insight into 
possible reaction intermediates, whereby analysis of the 
reaction mixture after 5 minutes using ESI mass spectroscopy 
revealed the presence of organometallic cobalt(III) 
intermediates. 
 
B. Examples using 2-arylpyridine and related substrates 
 
Scheme 8. Structures of 2-arylpyridine and related substrates. 
2-arylpyridine and arylpyrimidine substrates have been 
extensively used in metal-catalysed C-H functionalisation 
studies to exemplify novel bond formation reactions, most 
likely as a result of the relative ease of converting this 
substrate due to its rigid nature. The field of [Cp*Co(CO)I2] 
catalysed bond forming reactions is no exception to this, and a 
variety of interesting bond forming reactions have been 
reported using these and related substrates (Scheme 8 and 9). 
 Amidation of this class of substrate was first reported 
by Chang and co-worker in late 2014 (Scheme 9i).60 This 
protocol uses acetoxycarbamates as a reactive source of 
amide, with the authors reporting that C-N bond formation 
was not achievable with sulfonyl azides (N3-Ts; see Scheme 7i 
for previous successful application) using these substrate 
under the optimised reaction conditions. This exemplifies 
where protocols cannot be transferred to all classes of 
substrate. The protocol was found to be tolerant to a wide 
range of substituents on the aryl group and was also found to 
convert 6-arylpurine derivatives bearing sensitive functional 
groups, further enhancing the future applicability of the 
protocol. 
 Both the groups of Glorius and Ackermann have 
reported on the cyanation of 2-arylpyridines using NCTS 
(Scheme 9iv and v).27,56 Glorius and co-workers have also 
reported an example of iodination and bromination of 2-aryl 
pyridines, although yields of the bromination product were 
found to be low (Scheme 9ii)).27 In this example, N-
iodosuccinimide (NIS) and N-bromophthalimide (NBP) were 
employed as iodinating and brominating agents respectively. A 
range of other substrates were studied and provided modest 
conversions, although indole substrates were not trialled in 
this halogenation study and it is not clear if this class of 
compound could be successfully converted under the 
optimised reaction conditions. 
Further development and application of halogenation 
protocols has been achieved by Pawar and co-worker (Scheme 
9iii).61 This report describes the iodination and bromination of 
6-arylpurines. Not only could the protocol covert 6-arypurines, 
it is also able to convert 2-thiophenepurines, although other 
heterocyclic purines could not be successfully converted. 
 In addition to the amidation protocol reported by 
Chang and co-worker (Scheme 9i), amidation of 2-aryl 
pyridines and additionally, 6-arylpurine derivatives has been 
reported by Jiao and co-workers (Scheme 9vi).57 In contrast to 
  
the Chang amidation protocol, this example uses a 1,4,2-
dioxazol-5-one as amidating agent, extruding CO2 as by-
product. Aryl substrates using an oxime ether as directing 
group could also be converted in relatively modest yield. This 
conversion was also found to be more efficient when using the 
single component [Cp*Co(MeCN)3](SbF6)2 catalyst. 
Substituted 2-aryl oxazolines are found in a number of 
bioactive compounds and in 2015, Ackermann and co-workers 
provided an example of the successful use of the oxazoline 
moiety as directing group for C-H functionalisation (Scheme 
9vii).58 The work demonstrated that this class of substrates 
could be amidated using the commonly applied 1,4,2-dioxazol-
5-one compounds as amidating agent in combination with the 
[Cp*Co(CO)I2] catalyst. The authors were also able to 
successfully use substituted oxazolines and oxazines as 
directing groups. 
Alkenylation of 2-arylpyridines with terminal alkynes has 
been well studied by Chen/Yu and co-workers (Scheme 9viii).48 
In this report a range of substituted 2-arylpyridines and 
phenylacetylenes could be successfully coupled using the 
[Cp*Co(CO)I2] catalyst. When 2-arylpyrimidine substrates were 
employed, mixtures of mono- and di-functionalisation 
products were obtained and upon doubling the loading of 
phenylacetylene, the yield of the di-functionalised product was 
enhanced, although a mixture was still obtained. The 
alkenylation protocol could also be transferred to 6-arylpurine 
derivatives. 
 
Scheme 9. Examples of reported C-C and C-X Couplings using 2-arylpyridine and related substrates. General conditions for each example: (i) 0.10 mmol substrate, 
0.11 mmol acetoxycarbamate, 8.0 mol% [Cp*Co(CO)I2], 16 mol% AgSbF6, acetone, 60 
oC, 16 h. (ii) Iodination: 0.40 mmol substrate, 0.60 mmol N-iodosuccinimide 
(NIS), 10 mol% [Cp*Co(CO)I2], 20 mol% AgSbF6, 25 mol% NaOAc, 1,2-DCE, 70 
oC, 20 h. Bromination: 0.80-1.20 mmol substrate, 0.40 mmol N-bromophthalimide (NBP), 
10 mol% [Cp*Co(CO)I2], 20 mol% AgSbF6, 50 mol% PivOH, 60 
oC, 36 h. (iii) ) Iodination: NIS and Bromination: N-bromosuccinimide (NBS); 0.10 mmol substrate, 0.12 
mmol NIS or NBS, 5.0 mol% [Cp*CoI2]2, 20 mol% AgNTf2, 20 mol% AgOAc, TFE, 80 
oC, 12 h. (iv) 0.40 mmol substrate, 0.48 mmol N-cyano-N-phenyl-p-
toluenesulfonamide (NCTS), 2.5-5.0 mol% [Cp*Co(CO)I2], 5.0-10 mol% AgSbF6, 5.0-10 mol% NaOAc, 1,2-DCE, 110 
oC, 12-24 h. (v) 0.50 mmol substrate, 0.75 NCTS, 2.5 
mol% [Cp*Co(CO)I2], 5.0 mol% AgSbF6, 5.0 mol% KOAc, 1,2-DCE, 120 
oC, 16 h. (vi) 0.20 mmol substrate, 0.22 mmol 1,4,2-dioxazol-5-one, 2.5-5.0 mol% 
[Cp*Co(MeCN)3](SbF6)2, 1,2-DCE, 80 
oC, 12 h. (vii) 0.50 mmol substrate, 0.60 mmol 1,4,2-dioxazol-5-one, 5.0 mol% [Cp*Co(CO)I2], 20 mol% AgSbF6, 20 mol% NaOAc, 
1,2-DCE, 100 oC, 16 h. (viii) 0.20 mmol substrate, 0.20 mmol phenylacetylene, 5.0 mol% [Cp*Co(CO)I2], 10 mol% AgSbF6, 0.5 equiv. PivOH, 1,2-DCE, 60 
oC, 5 h. (ix) 0.10 
mmol substrate, 0.15 mmol allyl alcohol, 5.0 mol% [Cp*Co(CO)I2], 10 mol% AgOTf, 10 mol% AgOAc, TFE, 60 
oC, 8 h. (x) 0.5 mmol substrate, 0.6 mmol 
vinylcyclopropane, 10 mol% [Cp*Co(CO)I2], 20 mol% AgOTf, 20 mol% NaOPiv, 1,2-DCE, 50 
oC, 20 h. (xi) 0.20 mmol substrate, 0.24 mmol gem-difluorostyrene, 5.0 
mol% [Cp*Co(MeCN)3](SbF6)2, 2.0 equiv. Ca(OH)2, TFE, 45 
oC, 24 h. (xii) 0.20 mmol substrate, 0.25 mmol ketenimine, 2.5 mol% [Cp*Co(CO)I2], 7.5 mol% AgNTf2, 1,2-
DCE, 80 oC, 10 h. (xiii) 0.50 mmol substrate, 0.72 mmol allene, 5.0 mol% [Cp*CoIII(CO)I2], 10-15 mol% AgSbF6, 1,2-DCE or 1,4-dioxane, 100-120 
oC, 20 h. (xiv) 0.20 mmol 
  
substrate, 0.40 mmol AgSCF3, 5.0 mol% [Cp*CoI2]2, 20 mol% NaOPiv.H2O, 1,2-DCE, 100 
oC, 24 h. (xv) 0.40 mmol substrate, 0.60 mmol N-
trifluoromethylthiodibenzenesulfonimide, 10 mol% [Cp*Co(MeCN)3](SbF6)2, 5.0 mol% AgSbF6, 80 mg MS 3Å, 8 mL HFIP, 80 
oC, 12 h. 
 
 
Scheme 10. Examples of terminal couplings using benzamide substrates. 
Yoshino/Matsunaga and co-workers have described the 
dehydrative C-H allylation of 6-aryl purines using allyl alcohols 
as coupling partners (Scheme 9ix).62 The use of fluorinated 
solvent was found to be key, as the conversion was 
significantly retarded when using 1,2-DCE. 
Ackermann and co-workers, Li and co-workers and 
Lu/Wang and co-workers and have also extended the 
application of their alkylation,49 α-fluoroalkenylation50 and 
enaminylation52 protocols, to successfully include 2-
arylpyridine and related substrates (Scheme 9x-xii). Although, 
the enaminylation protocol only provided products in modest 
yield compared with indole-based substrates containing a 
pyrimidine directing group. In a similar way, Ackermann and 
co-workers transferred their hydroarylation protocol to 2-aryl 
pyridine and 2-arylpyrimidine substrates (Scheme 9xii),53 
although again observing reduced yields compared to the 
same conversions with indole-based substrates containing 
pyrimidine directing groups. 
Very recently, Wang and co-workers have presented the 
first trifluoromethylthiolation using [Cp*Co(CO)I2] as catalyst 
(Scheme 9xii).38 This conversion was found to only proceed 
with 2-arylpyridine and 2-arylpyrimidine substrates, with a 
range of other common classes of substrate (eg. indole-based 
substrates containing a pyrimidine directing group) the 
conversion failed. The optimised protocol provided a range of 
differently substituted trifluoromethylthiolated products in 
moderate yield. It was also found that both [Cp*RhIIICl2]2 and 
[Cp*IrIIICl2]2 were not competent catalysts for this conversion 
under the optimised conditions, demonstrating the sometimes 
differential activity of the [Cp*Co(CO)I2] catalyst. It should 
however be noted that in this case the [Cp*CoI2]2 dimer 
appears to show higher activity over the [Cp*Co(CO)I2] 
catalyst. In a more recent report Yoshino/Matsunaga and co-
workers have further extended the substrate scope and also 
included 6-arylpurines, employing N-
trifluoromethylthiodibenzenesulfonimide as trifluoromethyl 
source (Scheme 9xiv).63 The authors of this work also report 
that the single component catalyst, [Cp*Co(MeCN)3](SbF6)2, 
showed higher efficiency over the [Cp*Co(CO)I2]/AgSbF6 
catalyst system. 
C. Miscellaneous examples 
Besides the use of indole-based and 2-aryl pyridine/related 
substrates, couplings have also been successfully developed 
using other substrate classes. In this section, an overview of 
these couplings (not mentioned previously) will be presented. 
 Whilst cobalt-catalysed C-H functionalisation of 
benzamides is relatively well established using cobalt(II) salts, 
as a result of the pioneering work of Daugulis and co-worker,29 
there are few examples of terminal additions using the 
[Cp*Co(CO)I2]. In 2015 Kanai/Matsunaga and co-workers 
presented an example of C-H alkenylation of benzamides using 
ethyl acrylate (an allyl ester) as coupling partner (Scheme 
10a).64 In this example the authors propose that rather than 
the typical redox neutral catalytic cycle proposed in the 
majority of protocols using [Cp*Co(CO)I2], there is a reductive 
elimination and hence the requirement for the super-
stoichiometric AgOAc oxidant. This coupling was also able to 
be applied to acetanilides (Scheme 10b). In contrast, Glorius 
and co-workers reported a different reaction outcome by 
replacing the allyl ester with an allyl carbonate (Scheme 10c).41 
This latter protocol is also able to unusually convert 
alkenylamides (Scheme 10d), whilst replacement of the allyl 
carbonate with an allyl alcohol results in the same product, but 
significantly lower yield.  
Yoshino/Matsunaga and co-workers have also provided a 
methodology for allylating benzamide substrates. This protocol 
employs allyl alcohols as allylating agents (Scheme 10e).62 
Using this methodology the authors were able to prepare a 
synthetically useful functionalised Weinreb amide. 
In addition to these alkenylation and allylation reactions, 
Glorius and co-workers extended the substrate scope of their 
  
 
Scheme 11. Coupling of alkylbenzimidates with gem-difluoroalkenes reported by 
Li and co-workers. 
iodination protocol to include benzamide substrates (Scheme 
10f).27 The authors also provided unusual examples of 
iodination of N-alkenylbenzamides, further demonstrating 
potential applicability. 
Whilst Li and co-workers were exploring the potential of 
their α-fluoroalkenylation using alkylbenzimidates, the authors 
observed an unusual product outcome (Scheme 11).50 Rather 
than providing a simple terminal coupling as would be 
expected, the final product was actually a substituted 
benzonitrile, demonstrating further applicability of their 
protocol. 
Glorius and co-workers have demonstrated application of 
the [Cp*Co(CO)I2] catalyst for the facile formation of 
potentially relevant unnatural protected amino acids (Scheme 
12).65 The reaction proceeds by an intermolecular 
carboamination of the alkene, with the participating amine 
coming from a transfer from within the substrate itself. The 
authors also report contrasting reaction outcomes using 
Cp*CoIII and Cp*RhIII catalysis, which is rationalised to result 
from the increased propensity for β-H elimination with 
rhodium. 
In 2016, Yoshino/Matsunaga and co-workers reported on 
the alkenylation of dimethylcarbamoyl-protected pyrroles 
(Scheme 13a).66 The protocol was found to only mono-
alkenylate at the 2-position or 5-position when 
unsymmetrically substituted pyrroles were employed. Under 
the optimised reaction conditions rhodium catalysts do not  
 
Scheme 12. Example of differential outcome when coupling phenoxyacetamides 
with alkylacrylates using either cobalt or rhodium catalysts, reported by Glorius 
and co-workers. 
 
Scheme 13. Alkyne coupling to (a) pyrrole and (b) indole, using carbomyl 
directing groups.  
 
Scheme 14. C(sp3)-H functionalisation using [Cp*Co(CO)I2] and [Cp*CoI2]2 
catalysts. 
display any activity, again showing the distinct reactivity of 
Cp*CoIII. More recently, the same group provided a new 
coupling protocol with indole substrates bearing a carbomyl 
directing group with a range of alkynes. This new example also 
involved a directing group migration, providing access to a new 
family of tetrasubstituted alkenes (Scheme 13b).67 Rhodium 
catalysts were again found not to catalyse this reactivity 
pattern, whilst this new report is in contrast to previous work 
where the same substrate was converted to pyrroloindolones 
using the [Cp*Co(benzene)](PF6)2 catalyst.
68 
One of significant challenges in the C-H activation field 
concerns the functionalisation of C(sp3)-H bonds. In 2016, 
Sundararaju and co-workers described the alkenylation and 
amidation of 8-methylquinoline substrates using the 
[Cp*CoIII(CO)I2] catalyst (Scheme 14).
69,70 The alkenylation of 
this substrate builds on work reported by Wang and co-
workers using [Cp*RhCl2]2 as catalyst.
71 Interestingly, 
[Cp*CoI2]2 was found to exhibit increased activity over the 
[Cp*Co(CO)I2] catalyst for the amidation protocol. 
3. Heterocycle formation using Cp*Co
III
 catalysis 
Heterocyclic compounds are important motifs in a variety of 
key pharmaceutical and agrochemical compounds, with novel 
methods of for their preparation of great interest to the wider 
scientific community. Annulation reactions using alkynes as 
coupling partners are a powerful method for heterocycle 
formation and in this section, a diverse range of examples 
using [Cp*CoIII(CO)I2] catalysts will be discussed. For clarity, the 
couplings have been grouped by product type, as protocols 
detailing the preparation of indoles and isoquinolines have 
received particular attention. 
  
A. Protocols for the preparation of indoles 
One of the first examples of C-H functionalisation using 
[Cp*Co(CO)I2] for indole preparation was provided by 
Ackermann and co-workers in 2016 (Scheme 15i).72 This report 
described the synthesis of indoles starting from nitrones via a 
C-H/N-O functionalisation process in a regioselective manner. 
After conducting competition experiments the authors 
disclosed that electron-rich nitrones were significantly more 
reactive under the protocol. Additionally, electron-rich alkynes 
were also found to be more active, suggesting a kinetically 
relevant alkyne coordination during the mechanism. 
Interestingly, under the optimised conditions, the 
[Cp*Co(CO)I2] catalyst was found to be significantly more 
efficient compared to [Cp*RhCl2]2, which has previously been  
 
Scheme 15. Examples of preparation of indoles. General conditions for each 
example: (i) 0.50 mmol substrate, 0.75 mmol alkyne, 5.0 mol% [Cp*Co(CO)I2], 20 
mol% AgSbF6, 20 mol%, HFIP, 100 
oC, 16 h. (ii) 0.4 mmol substrate, 0.60 mmol 
alkyne, 2.0 mol% [Cp*CoI2]2, 8.0 mol% AgSbF6, 1.2 equiv. Zn(OTf)2, 1,2-DCE, 50
 oC, 
12 h. (iii) 0.20 mmol substrate, 0.4 mmol alkyne, 10 mol% [Cp*Co(CO)I2], 20 
mol% AgSbF6, 10 mol% Fe(OAc)2, 1.0 equiv. Ag2O, 1,2-DCE, 120 
oC, 12 h. (iv) 0.10 
mmol substrate, 0.15 mmol alkyne, 10 mol% [Cp*Co(CO)I2], 20 mol% AgSbF6, 2.0 
equiv. NaH2PO4, 1.2 equiv. Ag2CO3, 1,2-DCE, 130 
oC, 24 h. (v) 0.2 mmol substrate, 
0.3 mmol alkyne, 5.0 mol% [Cp*Co(MeCN)3](SbF6)2, 2.0 equiv Cu(OAc)2, 1,2-DCE, 
80 oC, 24 h. (vi) 0.8 mmol substrate, 0.40 mmol alkyne (yields based on alkyne), 
10 mol% [Cp*Co(CO)I2], 20 mol% AgSbF6, 10 mol% KOAc, HFIP, 80
 oC, 22 h. 
used to catalyse protocols for indole formation. Whilst 
cobalt also provides significant improvement in 
regioselectively when utilising unsymmetrical alkynes as 
coupling partners.73 The authors also disclosed that the single 
component catalyst, [Cp*Co(MeCN)3](SbF6)2, was also able to 
efficiently provide indole products, thus removing the 
necessity for addition of a silver salt. 
Zhu and co-workers have also reported an example of 
indole preparation utilising a cobalt-catalysed C-H activation 
approach (Scheme 15ii).74 In this report arylhydrazines were 
used as substrates with both internal and terminal alkynes 
successfully employed. Excellent regioselectivity was again 
observed with this protocol and as mentioned, terminal 
alkynes could also be coupled, although in order to furnish 
improved yields it was necessary to use 
[Cp*Co(MeCN)3](SbF6)2. This necessity was in agreement with 
the authors previous similar work with rhodium, where the 
counterion was shown to inhibit activity.75 
Simultaneously, both the groups of Glorius and Shi 
reported the use of N-arylureas as substrates for indole 
formation (Scheme 15iii and iv).76,77 Both reports highlight the 
importance of a stoichiometric oxidant, indicating the 
likelihood of a key reductive elimination step in the 
mechanism. In addition, Shi and co-workers demonstrated that 
the use of less electrophilic ureas other than acetamides as 
directing groups is crucial for the reaction to proceed. In the 
absence of oxidant and addition of a Lewis acid, Glorius and  
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Scheme 16. (a) Different mechanistic pathways for the preparation of quinolines (Cycle A) and indoles (Cycle B) from the same starting material reported by Glorius 
and co-workers. (b) Reaction conditions reported for the preparation of indoles and quinolines. (c) Preparation of quinoline-N-oxide reported by Zhang and co-
workers.
 
co-workers were able to selectively obtain quinolines, a 
transformation which will be discussed in the next part of this  
section. Shi and co-workers also observed a similar switch in 
reaction outcome when using acetanilide as substrate. 
Jiao and co-worker have also reported a methodology for 
the preparation of indoles using N-nitrosoanilines as 
substrates (Scheme 15v).78 The group reported that the 
[Cp*Co(CO)I2] catalyst did not exhibit any reactivity for this 
reaction. As an alternative, the authors successfully employed 
the single component [Cp*Co(MeCN)3](SbF6)2 catalyst. It is 
worth mentioning that the lack of activity using [Cp*CoIII(CO)I2] 
was not surprising considering that it was not used in the 
presence of a silver salt such as AgSbF6. One key finding in this 
report was that alkynes bearing electron-deficient groups 
could be successfully employed as coupling partners, in 
contrast to unsuccessful reaction outcomes using 
[Cp*Rh(MeCN)3](SbF6)2. Furthermore, when using cobalt 
catalysis, the regioselectivity of the reaction is increased 
compared with corresponding rhodium catalysis. 
In a final example, Glorius and co-workers, developed a 
protocol for indole preparation using an oxidising directing 
group, thus removing the requirement for an additional 
stoichiometric oxidant (Scheme 15vi).79 This protocol was fully 
optimized and the most potent substrate was found to be the 
Boc-phenylhydrazine. Once again, the [Cp*Co(CO)I2] catalyst 
proved to have superior reactivity compared to [Cp*RhCl2]2. 
B. Protocols for the preparation of quinolines and 
isoquinolines 
Before embarking on a discussion of the examples of 
quinoline and isoquinoline preparation using cobalt catalysis, 
the work of Glorius and co-workers demonstrating the 
preparation of indole/quinoline compounds should be first 
mentioned (Scheme 16b).76 This work provides a mechanistic 
link between the two compound-types, both being annulation 
reactions using alkynes. In their report in 2016, Glorius and co-
workers demonstrated that through control of the additive 
(either oxidant or Lewis acid), the formation of either indole or 
quinoline could be controlled (Scheme 16). It was also found 
that the R group of the amide was also important, with urea’s 
reacting faster than alkyl amides in the indole synthesis 
protocol. This was reasoned to result from both a dehydrative 
(Scheme 16a, cycle A) and reductive elimination (Scheme 16a, 
cycle B) being key steps in the respective mechanisms, 
resulting in the realisation of two different products. Just 
before this report, Li and co-workers reported on the same 
transformation, albeit using different conditions (Scheme 
16b).80 This work provided a wide functional group tolerance, 
with relatively high regioselectivity when unsymmetrical 
alkynes were employed as coupling partners. The conversion 
did not occur when the pivaloyl or trifluoroacetyl amides were 
  
used as substrates, indicating that electronic and steric effects 
of the amide group are important considerations. 
 More recently, Zhang and co-workers have disclosed 
a method for the preparation of quinoline-N-oxides through 
the coupling of arylnitrones with alkynes (Scheme 16c).81 In 
this report, it was found that only 2,6-dichlorophenyl (DCP) 
and 2,6-difluorophenyl derivatives could be converted. The 
protocol displays a wide substrate scope, aside from the use of 
aliphatic alkynes and ortho-substituted arylnitrones, which 
result in low yield or no conversion, respectively. The 
quinoline-N-oxide product can easily be converted to the 
corresponding quinoline by reaction with sodium ethoxide in 
PhCH2OH, whilst the N-oxide can also be used as a directing 
group for further transition metal-catalysed C-H 
functionalisation on the aryl-ring of the quinoline. 
Isoquinolines are the building blocks for numerous 
pharmaceuticals thus; their synthesis has been of interest over 
the past few years. One of the first groups to have successfully 
synthesised isoquinolines via a high-valent cobalt C-H 
functionalization approach was Sundararaju and co-workers in 
2015 (Scheme 17ai).82 This was achieved by dehydrative 
annulation of oximes with different alkynes using 
[Cp*Co(CO)I2]. A notable observation is that the reaction took 
place without any external oxidants. The group confirmed that 
the OH group plays an important role in the catalytic cycle by 
replacing the OH with OMe and OAc, which dramatically 
reduced the yields of product. Various substituted oximes 
were used for the substrate scope, with high yields being 
obtained for ortho, meta and para substituted oximes. 
Furthermore, sterically complex substituents also provided 
high yields.  
 
Scheme 17. (a) Examples of preparation of isoquinolines. General conditions for 
each example: (i) 0.2 mmol substrate, 0.24 mmol alkyne, 10 mol% [Cp*Co(CO)I2], 
20 mol% AgSbF6, 20 mol% NaOAc TFE, 80 
oC, 24 h. (ii) 0.50 mmol substrate, 0.75 
mmol alkyne, 10 mol% [Cp*Co(CO)I2], 20 mol% AgSbF6, 20 mol% NaOAc, 1.2-
DCE, 120 oC, 16 h. (iii) 0.15 mmol substrate, 0.18 mmol alkyne, 10 mol% 
[Cp*Co(CO)I2], 20 mol% AgSbF6, 20 mol% KOAc, 1,2-DCE, 80-120 
oC, 24 h. (iv) 
0.20 mmol substrate, 0.24 mmol alkyne, 10 mol% [Cp*Co(CO)I2, 20 mol% AgNTf2, 
1.0 equiv. HOAc, 1,2-DCE, 120 oC, 18 h. (v) 0.13 mmol substrate, 0.10 mmol 
alkyne (yield based on alkyne conversion), 10 mol% [Cp*Co(CO)I2, 20 mol% 
AgSbF6, 25 mol% PivOH, TFE, 120 
oC, 14 h. (b) Preparation of isoquinolines using 
diazo compounds. (c) Prepartion of 1-aminoisoquinolines, involving a directing 
group deacylation. 
Almost simultaneous to this report, both Ackermann and 
co-workers and Kanai/Matsunaga and co-workers 
demonstrated that the OH group from oximes could be 
replaced with OAc to obtain high yields (Scheme 17aii and 
iii).83,84 Interestingly, this latter report clearly focused on the 
use of terminal alkynes, providing significantly enhanced yields 
and site selectivity compared with the use of [Cp*RhCl2]2. 
In 2016, Li and co-workers provided a further example of 
isoquinoline preparation assisted by an oxidising N-S bond 
(Scheme 17aiv).85 The catalytic reaction was found to tolerate 
a range substituents on the imine, thus expanding on the 
scope of previous reports in this field. 
Another example of isoquinoline preparation using alkynes 
as coupling partners was reported by Pawar and co-workers 
(Scheme 17av).86 In this report, easily prepared arylhydrazones 
were used as substrates, employing an N-N bond as an internal 
oxidant. In this protocol, terminal alkynes were not 
successfully converted. 
All the [Cp*Co(CO)I2] catalysed annulation reactions 
discussed so far have used alkynes as a coupling partner. In 
2016, Ackermann and co-workers reported a different 
approach towards the preparation of isoquinolines via the 
reaction between aryl amidines with diazo compounds 
(Scheme 17b).87 This protocol provides a novel route towards 
1-aminoisoquinolines with significant substrate scope. It was 
noted that both electron donating and electron withdrawing 
groups were tolerated, although competition reactions 
demonstrated that substrates with electron donating 
functionalities were more easily converted than electron 
withdrawing ones. 
 Most recently, in 2017, Zhu and co-workers have 
used aryloxadiazoles as substrates for the formation of 1-
aminoisoquinolines, using alkynes as coupling partners 
(Scheme 17c).88 The final product in this example is realised 
through a deacetylation of the directing group, providing 
access to potentially useful amino substituted isoquinolines. 
The protocol provides a wide substrate scope, although when 
unsymmetrical alkynes are used, the regioselectivity is modest. 
C. Miscellaneous examples 
Even though significant attention has been paid to the 
synthesis of indoles, quinolines and isoquinolines, a range of 
other heterocycles have also been prepared using the 
[Cp*Co(CO)I2] catalysts. 
 Whilst dioxazolones have been successful employed 
as coupling partners for terminal amidation protocols, they 
have also found utility as reagents for the synthesis of 
heterocyclic compounds (Scheme 18). To this end, in 2016, Li 
and co-workers described a first C-H functionalisation 
methodology for the preparation of quinazolines from both N-
sulfinylimines and benzimidates using dioxazolones as 
  
amidating agent (Scheme 18i and ii).89 In this report, the 
authors use dioxazolones as nitrile sources, and disclose that in 
comparison, selectivity to the desired product was not 
successfully obtained using either iridium or rhodium catalysis. 
Both substrate types examined displayed wide substrate 
scope, resulting in the facile generation of two distinct families 
of quinazolines. 
 
Scheme 18. Examples of heterocyclic compounds prepared using dioxazolones. 
 
Scheme 19. Examples of coumarin and isocoumarin preparations. 
More recently, Chen and co-workers reported on a 
microwave assisted preparation of thiadiazine-1-oxide 
compounds (Scheme 18iii).90 Novel protocols for the synthesis 
of these compounds are highly desirable due to their 
properties as pharmaceutical agents, with current 
methodologies showing significant potential for improvement. 
Whilst Bolm and co-workers have provided a rhodium-
catalysed protocol, significant organic waste is produced due 
to the necessary removal of a Boc group,91 this new 
[Cp*Co(CO)I2] catalysed methodology shows improvement 
over the rhodium example, producing only CO2 and water as 
waste. 
One-pot reactions, where sequential reactions can be 
performed without intermediate work-up, are gaining interest 
as purification is often costly and generates significant solvent 
wastes. The simplicity and power of the terminal amidating 
protocol lends itself well to being involved in one-pot 
reactions. In 2017, both the groups of Li and Zhu reported on 
one-pot procedures for the preparation of quinolone 
compounds starting from aryl enaminone substrates (Scheme 
18iv and v).92,93 
 
Scheme 20. Examples of protocols for the preparation of isoquinolin-3-ones 
using diazo compounds as coupling partners. 
Both coumarin and isocoumarin compounds and their 
derivatives are recognised for their pharmacological and 
optical properties. In 2015, Wang and co-workers reported on 
the preparation of a range of coumarins through the coupling 
of CO with 2-alkenylphenols (Scheme 19a).94 The annulation 
was achieved using only a balloon of CO and the potential 
applicability of this protocol was demonstrated through the 
rapid total synthesis of three natural products. 
More recently, Sundararaju and co-workers have prepared 
isocoumarins through the annulation of readily-available 
carboxylic acids with alkynes (Scheme 19b).95 The procedure 
displays a wide substrate scope and using this protocol it was 
possible to achieve the desired products from methacrylic 
acid, although low yields were obtained from acrylic acid. This 
is a rare example of carboxylic acid as a directing group in high-
valent cobalt-catalysed C-H functionalisation protocols. 
Using diazo esters as coupling partners, Glorius and co-
workers have described two separate protocols for the 
preparation of isoquinolin-3-ones (Scheme 20).96,97 In their 
first example, in 2015, a wide range of 2-arylpyridines were 
successfully annulated, providing highly conjugated 
isoquinolin-3-one derivatives. It was noted that all the 
compounds obtained were brightly fluorescent, resulting from 
their extended π-systems. It is proposed that the 
[Cp*Co(CO)I2] catalyst is better suited to this conversion than 
[Cp*RhCl2]2, because the cobalt is able to act as both catalyst 
for the C-H activation step and, importantly, as a Lewis acid for 
the cyclisation step. 
In their more recent example, the Glorius group have used 
imines as substrates, again taking advantage of diazo esters as 
highly reactive coupling partners. The protocol displays a wide 
substrate scope with good functional group tolerance. 
Addition of an external Lewis acid, B(C6F5)3, was found to be 
key. This additive is suggested to play two distinct roles; 
  
generation of the catalytically active cobalt species and 
acceleration of the C-H activation step. 
N-heterocyclic quaternary ammonium salts are found in 
the core structures of many bioactive compounds and 
pharmaceuticals. The synthesis of quaternary ammonium salts 
using the [Cp*Co(CO)I2] catalyst was reported in 2016 for a 
diverse range of substrates by Cheng and co-workers, Wang 
and co-workers and Li and co-workers (Scheme 21).98-100 In the 
work by Chen and co-workers (Scheme 21a-c),98 2-
arylpyridines, azobenzenes, aryl ketimines and 2-vinylpyridines  
 
Scheme 21. Examples of N-heterocyclic quaternary salts through alkyne 
annulation protocols. 
were successfully annulated using alkyne coupling partners to 
provide the corresponding quaternary heteroaromatic 
ammonium salts, although regioselectivity was low when using 
unsymmetrical alkynes. The ammonium salt products could 
easily be converted, in high yield, into the corresponding 
amines. Furthermore, the products obtained from 
azobenzenes displayed strong blue photoluminescence with a 
narrow bandwidth, making them potentially interesting 
compounds for use in organic light-emitting diodes (OLEDs). 
Li and co-workers employed a similar approach with the 
well-known indole-based substrates bearing a pyridyl directing 
group, providing access to a wide range of annulated 
ammonium salts, which again could be further converted to 
the corresponding amine through reduction with NaBH4  
 
Scheme 22. Examples of heterocyclic compounds derived from aryl imidates. 
(Scheme 21d).99 The authors reported substitution on the 
pyridyl directing group enhanced or suppressed catalytic 
activity. Including a methyl group at the C-2 or C-3 position 
affords high yields of product, whilst including a methyl group 
at the C-1 or C-4 positions completely inhibited reactivity. 
In addition, Wang and co-workers have also provided a 
route to several different heterocyclic quaternary ammonium 
salts (Scheme 21e-g).100  
 Li and co-workers have used anthranils as coupling 
partners with aryl imidate substrates to access 1H-indazoles 
(Scheme 22a).101 In this example the anthranil coupling partner 
also acts as an organic oxidant. The single component 
[Cp*Co(MeCN)3](SbF6)2 catalyst provided enhanced yields over 
the [Cp*Co(CO)I2]/AgSbF6 catalyst system. The authors also 
suggest that the N-N bond formation likely involves a nitrogen 
radical intermediate species formed by a SET step, resulting 
from the catalytic amounts of copper used in the protocol. 
Vinylethylene cyclic carbonates (VEC’s) have shown significant 
potential as coupling partners in several synthetic protocols as 
a result of their facile preparation and, analogously to 
dioxazolones, only releasing CO2 as waste.
102-104 Recently, 
Ackermann and co-workers have used aryl imidate substrates 
and VEC’s to provide an unusual domino C-H/N-H allylation 
(Scheme 22b).105 During optimisation studies the use of either 
[Cp*Co(CO)I2] or the single component [Cp*Co(MeCN)3](SbF6)2 
furnished low yields of the annulated product. In contrast, high 
yields were obtained when the single component catalyst, 
[Cp*CoIII(MeCN)3](PF6)2, was employed. It is also noteworthy 
that rhodium catalysis was observed to be less efficient than 
cobalt catalysis for this conversion. 
The synthesis of pyrroles has attracted interest because of 
they are building blocks for a number of medicinal compounds. 
  
In 2016, Zhang and co-workers developed a [Cp*Co(CO)I2] 
catalysed approach for the facile preparation of multi-
substituted pyrroles by coupling enamides with alkynes 
(Scheme 23a).106 The catalytic system showed high tolerance 
for various electron withdrawing and electron donating groups 
and can be operated on a gram-scale. However, alkyl 
substituted enamides were found to afford lower yields due to 
decomposition. Compared with analogous palladium catalyst 
systems, this new protocol presents increased 
regioselectivity.107,108 
Zhang and co-workers have also developed a protocol for 
the preparation of indenones from readily available benzoic 
 
Scheme 23. Further examples of heterocyclic compound preparation using 
cobalt catalysis. 
esters and alkynes (Scheme 23b).109 The [Cp*Co(CO)I2] catalyst 
was found to display unique reactivity over the [Cp*RhIIICl2]2 
catalyst for this conversion. Unfortunately, the regioselective 
coupling of unsymmetrical alkynes presents a challenge that 
the optimised catalyst system was unable to overcome, 
providing a future opportunity for further improvement of this 
protocol. 
Whilst there are a significant number of reported couplings 
for forming heterocyclic products using alkynes as coupling 
partners, the potential of allenes has been relatively 
overlooked. Cheng and co-workers have developed a protocol 
for the preparation of 2H-chromenes via a facile coupling of 2-
vinylphenols with allenes, where the allene is a one-carbon 
coupling partner (Scheme 23c).110 This was the first example 
that used allenes for couplings with [Cp*Co(CO)I2] in catalysed 
C-H functionalisation protocols. The scope of 2-vinylphenols 
revealed generally high yields, but electron-donating methoxy 
substituents resulted in significantly reduced yields. The 
mechanism is proposed to proceed via the C-H activation of 
the vinyl group, allene insertion and a final intramolecular 
regioselective phenoxide addition. 
 Coupling of aldehydes with 2-aryl pyridines and 2-
alkenyl pyridines, furnishing indolizines has been reported by 
Zeng and co-workers (Scheme 23d).111 In this example, as with 
the example of Glorius previously (Scheme 20), the authors 
suggest that the cobalt catalyst is playing the dual role of both 
C-H activation and Lewis acid catalyst. The protocol displays 
excellent functional group tolerance with respect to the 
substrate, but clear limitations were observed when examining 
the aldehyde scope. Ethyl oxoacetate, oxo-aryl acetaldehyde 
and oxo-alkyl acetaldehyde were successfully coupled, but 
aldehydes such as benzaldehyde and acetaldehyde were not 
suitable for the optimised protocol. This example is similar to 
work reported by Ellman and co-worker, using the 
[Cp*Co(benzene)](PF6)2 catalyst.
26a 
 Jegamohan and co-workers have reported the 
annulation of N-methoxybenzamides with alkynes (Scheme 
23e).112 The authors demonstrated that the isoquinolone 
products could easily be converted into potentially useful 1-
halo substituted isoquinoline derivatives using either PBr3 or 
POCl3 for bromo- and chloro- products, respectively. In 
another example, Pawar and co-workers have recently 
described a facile route towards indolizidines (Scheme 23f).113 
The protocol utilises readily prepared aryl amides and 
alkynediones as coupling partners. The reaction tolerates both 
electron-withdrawing and electron-donating functional 
groups. It is notable that the group used the optimised 
conditions for late-stage functionalisation of estrone 
derivatives. Both of these reports are intriguing interesting as 
they do not require addition of any silver salts even though the 
[Cp*Co(CO)I2] catalyst is employed. 
4. Experimental evidence for organometallic 
intermediates in cobalt-catalysed C-H 
functionalisation protocols 
Even though high-valent approaches towards cobalt-catalysed 
C-H functionalisation are advancing at a rapid rate, surprisingly 
little attention has been directed towards either the detection 
or isolation of the commonly proposed Co(III) organometallic 
intermediate species. Indeed, to the best of our knowledge 
there is only one report of a Cp*CoIII organometallic complex 
formed by a direct C-H activation event. In 2001, Avilés and co-
workers demonstrated that reaction of [Cp*Co(PPh3)I2] with an 
azobenzene substrate, in the presence of AgBF4, furnished the 
corresponding cyclometallated product (Scheme 24).22 
Conclusive evidence for the formation of the organometallic 
  
product was provided by X-ray crystallographic and 
multinuclear NMR studies. It should be noted that once 
isolated no further reactivity studies were attempted. More 
recently, Kanai/Matsunaga and co-workers have isolated a 
cobaltocycle using the 2-phenylpyridine substrate, although 
they authors prepared the compound by a transmetallation 
using an organozinc species and not a direct C-H activation.69 
Other examples of isolation of organometallic cobalt 
species prepared through direct C-H activation have been 
obtained starting from cobalt(II) salts or cobalt(II) coordination 
compounds. As long ago as 1986, Broderick/Legg and co-
workers isolated organometallic cobalt species using a 
quadridentate macrocycle ligand, “dacoda” (1,5-
diazacyclooctane-N,N’-diacetic acid).20,21 In this work, the 
authors were also able to identify a weak agostic interaction 
between the intermediate cobalt(III) coordination complex and 
the hydrogen atom to be abstracted (Scheme 25). This agostic 
interaction was identified from the X-ray structure of the 
cobalt(III) coordination compound. This work indicates that 
cobalt(III) is the actual species which activates the C-H bond, 
through a weak two-electron, three-centre intermediate. 
 
Scheme 24. Preparation of a Cp*CoIII organometallic complex formed by a direct 
C-H activation. 
 
Scheme 25. Stepwise organometallic cobaltation described by Broderick/Legg 
and co-workers. 
 
Scheme 26. Detected/isolated organometallic cobalt(III) species containing the 
8-aminoquinoline directing group. 
 Over recent years several groups have either isolated 
or obtained mass-spectrometric evidence of organometallic 
cobalt(III) intermediates using substrates bearing the 8-
aminoquinoline directing group (Scheme 26).29,114-116 All of 
these reports utilise cobalt(II) salts, hence requiring an in-situ 
oxidation of the cobalt, as was observed in the example of 
Broderick/Legg and co-workers. In these studies, Maiti and co-
workers have also proved that their isolated intermediate was 
catalytically competent. 
Most recently, Ribas and co-workers have provided an 
extensive study into the formation of organometallic cobalt 
species in C-H functionalisation protocols.115 In this work a 
macrocyclic platform was used to stabilise the organometallic 
intermediate resulting from the C-H activation of an C(sp2)-H 
bond (Scheme 2). The authors were able to isolate and 
thoroughly characterise both the cobalt(II) co-ordination 
complexes and also the organometallic cobalt(III) species, 
including X-ray crystal structures and an EXAFS study. 
Furthermore, reactivity studies using alkynes as coupling 
partners provided important insights into high-valent cobalt-
catalysed annulation protocols which operate through a key C-
H activation step. 
 
Scheme 27. Stepwise cobaltation described by Ribas and co-workers. 
5. Summary and outlook 
Over the past few years, there has been an explosion in the 
use of [Cp*Co(CO)I2] catalysts in direct C-H bond 
functionalisation protocols, since the initial report by Kanai 
and Matsunaga. In many cases this powerful cobalt catalyst 
  
presents differing reactivity profiles to analogous rhodium 
catalysts. This is likely due to the lower electronegativity and 
increased Lewis acidity of cobalt compared to rhodium and a 
number of researchers have used this to their advantage when 
designing new catalytic protocols. Furthermore, the cost and 
relative low toxicity of cobalt make this an appealing metal to 
use. Whilst significant strides are being made with individual 
couplings, and as some groups have demonstrated, integration 
of [Cp*Co(CO)I2] catalysed reactions into multi-step one-pot 
procedures to provide rapid and facile access to highly 
complex molecules remains an intriguing opportunity. Whilst, 
significant attention should also be directed to the 
development of highly challenging, yet potentially powerful 
C(sp3)-H functionalisations.  
Given the still unexplored full potential of [Cp*Co(CO)I2] 
catalysts, we expect that new exciting and diverse protocols 
will be developed over the coming years using the 
[Cp*Co(CO)I2] catalysts, making cobalt catalysed C-H 
functionalisation a key tool in the synthetic chemists’ toolbox. 
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